Healthcare Technology Trxade explores alternative ways to find partners for B2C assets: CEO Suren Ajjarapu 2 years ago Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company that is on a mission to enable independent pharmacies… Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows 2 years ago Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a modest decline in its third-quarter revenues. Meanwhile,… Why AngioDynamics (ANGO) deserves a place on investors’ watchlist 2 years ago The market reopening has created a conducive atmosphere to carry out elective medical procedures which were deferred on a large… Trxade Health Inc. (NASDAQ: MEDS) Q3 2022 Research Summary 2 years ago Trxade Health Inc. (NASDAQ: MEDS) is an integrated drug delivery platform that offers a digitalized retail pharmacy experience to independent… Trxade will focus more on core biz, connect with POS systems: CEO Suren Ajjarapu 2 years ago Trxade Health Inc. (NASDAQ: MEDS) has been on a mission to digitalize the retail pharmacy experience by providing a platform… MEDS Earnings: Trxade Health Q2 revenues surge 73% amid continued user growth 2 years ago Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a sharp increase in its second-quarter 2022 revenues.… Trxade Health Inc. (NASDAQ: MEDS) Q1 2022 Research Summary 3 years ago Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It… Trxade will stay focused on traditional technology platform for margin growth: CEO Suren Ajjarapu 3 years ago Can you briefly talk about your business model and the value you add to the market? Trxade (NASDAQ: MEDS) is… Trxade Health Inc. (NASDAQ: MEDS) Q4 2021 Research Summary 3 years ago Trxade Health Inc. (NASDAQ: MEDS) is a healthcare service technology platform that mainly serves the secondary pharmaceutical supply chain, offering… Champions Oncology, Inc. (CSBR) Q2 2022 Earnings Call Transcript 3 years ago Champions Oncology, Inc. (NASDAQ: CSBR) Q2 2022 earnings call dated Dec. 13, 2021. Corporate Participants: Ronnie Morris -- President & Chief Executive… Trxade CEO Suren Ajjarapu: Will see the impact of GPO program by Q3 next year 3 years ago Image: iStock Give us a quick overview of the company. Trxade is a market platform that caters to the independent… Trxade Health beats on Q3 revenue estimate 3 years ago Trxade Health Inc (NASDAQ: MEDS) on Monday posted third-quarter revenues of $2.6 million, down year-over-over as a result of non-recurring… IPO News: What to look for when Healthcare Triangle goes public 3 years ago The global healthcare information technology market was valued at $74.2 billion in 2020, and it is expected to grow at… iFIT Health & Fitness to raise $600 mln in IPO. Here’s what you need to know 3 years ago The technology and healthcare industries have dominated the IPO market in the recent past, but it seems the spotlight is… Trxade Health Inc. (NASDAQ: MEDS) Q3 2021 Research Summary 3 years ago It is estimated that the North American e-Pharmacy market would grow at a compound annual rate of 14.8% through 2025.… « Previous